|
|
|
| home > ebr > spring 2003 > assessing the safety of inhaled biopharmaceuticals - current issues and recent developments |
|
|
 PUBLICATIONS |
European Biopharmaceutical Review
|
It has long been recognised that inhalation is a very efficient means of introducing foreign substances into the body. As long as 500 years ago, Leonardo da Vinci realised that inhaled dust could cause lung pathology and so annotated one of his anatomical drawings of lungs - in his characteristic mirror writing - "polvere fa danno" or "dust causes damage".
The importance of inhalation as a route of exposure to injurious substances has long been recognised. For example ...
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
BIO-Europe Spring® 2012 — 6th International Partnering Conference
19-21 March 2012, Amsterdam RAI Convention Center, Amsterdam, The Netherlands
BIO-Europe Spring is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative start-ups.
More info >> |
|
 |
News and Press Releases |
 |
Pantec Biosolutions to Present P.L.E.A.S.E.® Professional for Transdermal Drug Delivery at DDP in Las Vegas
Pantec Biosolutions AG, the developer and manufacturer of P.L.E.A.S.E.® Professional, a state of the art portable laser device that sets new standards for safety, precision and versatility, today announced that it will be giving a scientific company presentation during the “Drug Delivery Partnerships” conference from 25th -27th January 2012 in Las Vegas, USA.
More info >> |
|
|
